MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on June 5, 2006; DOI: 10.1124/mol.105.019547


0026-895X/06/7003-806-817$20.00
Mol Pharmacol 70:806-817, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.019547v1
70/3/806    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hänggi, E.
Right arrow Articles by St-Pierre, M. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hänggi, E.
Right arrow Articles by St-Pierre, M. V.

Functional Analysis of the Extracellular Cysteine Residues in the Human Organic Anion Transporting Polypeptide, OATP2B1

Emanuel Hänggi, Anne Freimoser Grundschober, Simone Leuthold, Peter J. Meier, and Marie V. St-Pierre

Division of Clinical Pharmacology and Toxicology, Department of Medicine, University Hospital Zürich, Zürich, Switzerland

Organic anion transporting polypeptide (OATP) superfamily member 2B1 (OATP2B1) mediates the uptake of steroid hormone precursors and selected drugs in the placenta, liver, mammary gland, brain, and intestine. This action is modulated by sulfhydryl reagents. Common to all OATPs is a large extracellular loop between transmembrane domains IX and X with 10 conserved cysteines. To elucidate the structure-function relationship of this cysteine rich ectodomain, a truncated OATP2B1 lacking 10 extracellular cysteines (OATP2B1{Delta}489-557) and 10 OATP2B1 mutants containing individual Cys-to-Ala substitutions were generated and expressed in CHO-K1 cells. The immunolocalization, cell-surface expression, transport activity, and free cysteine labeling with N-biotinoylaminoethylmethane-thiosulfonate of mutant proteins and wild-type OATP2B1 were compared. OATP2B1{Delta}489-557 accumulated intracellularly. Nine Cys-to-Ala substitutions, C489A, C495A, C504A, C516A, C520A, C539A, C541A, C553A, and C557A, were misprocessed, appearing predominantly as core-glycosylated, 60-kDa proteins and as 180-kDa complexes. Only C493A was a fully glycosylated 75-kDa protein expressed at the cell surface. Thapsigargin partially corrected the misprocessing of mutants. Compared with OATP2B1, C493A and C557A transported estrone-3-sulfate and dehydroepiandrosterone sulfate less efficiently, whereas all other mutants were functionally impaired. MTSEA labeled free cysteines in all Cys-to-Ala mutants but not in OATP2B1, suggesting that all 10 extracellular cysteines are normally disulfide-bonded. Our findings show that the trafficking and function of OATP2B1 is vulnerable to changes in the cysteine residues of extracellular loop IX-X.


Received for publication November 2, 2005.

Accepted for publication May 22, 2006.

Address correspondence to: Marie V. St-Pierre, Division of Clinical Pharmacology and Toxicology, University Hospital Zürich, 100 Rämistrasse, Zürich 8091, Switzerland. E-mail: stpierre{at}kpt.unizh.ch




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
J. Niessen, G. Jedlitschky, M. Grube, S. Bien, H. Schwertz, S. Ohtsuki, H. Kawakami, J. Kamiie, S. Oswald, K. Starke, et al.
Human Platelets Express Organic Anion-Transporting Peptide 2B1, an Uptake Transporter for Atorvastatin
Drug Metab. Dispos., May 1, 2009; 37(5): 1129 - 1137.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
A. Mulenga, R. Khumthong, K. C. Chalaire, O. Strey, and P. Teel
Molecular and biological characterization of the Amblyomma americanum organic anion transporter polypeptide
J. Exp. Biol., November 1, 2008; 211(21): 3401 - 3408.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics